Cargando…

Rituximab‐treated patients with lymphoma develop strong CD8 T‐cell responses following COVID‐19 vaccination

B‐cell depletion induced by anti‐cluster of differentiation 20 (CD20) monoclonal antibody (mAb) therapy of patients with lymphoma is expected to impair humoral responses to severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) vaccination, but effects on CD8 T‐cell responses are unknown. Here...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riise, Jon, Meyer, Saskia, Blaas, Isaac, Chopra, Adity, Tran, Trung T., Delic‐Sarac, Marina, Hestdalen, Malu Lian, Brodin, Ellen, Rustad, Even Holth, Dai, Ke‐Zheng, Vaage, John Torgils, Nissen‐Meyer, Lise Sofie Haug, Sund, Fredrik, Wader, Karin F., Bjornevik, Anne T., Meyer, Peter A., Nygaard, Gro O., König, Marton, Smeland, Sigbjørn, Lund‐Johansen, Fridtjof, Olweus, Johanna, Kolstad, Arne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Covid‐19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111866/ https://www.ncbi.nlm.nih.gov/pubmed/35254660 http://dx.doi.org/10.1111/bjh.18149

Ejemplares similares

Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants
por: Meyer, Saskia, et al.
Publicado: (2023)

PB2501: INSIGHT-1: A PHASE I FIRST-IN-HUMAN TCR TRIAL OF GENETICALLY MODIFIED T-CELLS TARGETING TDT IN CHILDREN AND ADULTS WITH T- AND B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA (TRIAL-IN-PROGRESS)
por: Buechner, Jochen, et al.
Publicado: (2023)

Prevalence of antibodies against SARS‐CoV‐2 in the Norwegian population, August 2021
por: Tunheim, Gro, et al.
Publicado: (2022)

Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
por: König, Marton, et al.
Publicado: (2022)

Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
por: Kared, Hassen, et al.
Publicado: (2022)

Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study
por: Jorgensen, Kristin, et al.
Publicado: (2022)

Paired opposing leukocyte receptors recognizing rapidly evolving ligands are subject to homogenization of their ligand binding domains
por: Fossum, Sigbjørn, et al.
Publicado: (2011)

Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic
por: Tunheim, Gro, et al.
Publicado: (2021)

T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
por: Wolf, Asia-Sophia, et al.
Publicado: (2023)

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
por: König, Marton, et al.
Publicado: (2023)

PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy
por: Sponaas, Anne-Marit, et al.
Publicado: (2015)

Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
por: Tran, Trung The, et al.
Publicado: (2022)

Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
por: Tran, Trung The, et al.
Publicado: (2023)

Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients
por: Kared, Hassen, et al.
Publicado: (2023)

Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
por: Jyssum, Ingrid, et al.
Publicado: (2022)

A systematic safety pipeline for selection of T-cell receptors to enter clinical use
por: Foldvari, Zsofia, et al.
Publicado: (2023)

Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment
por: Hultcrantz, Malin, et al.
Publicado: (2020)

Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy
por: Syversen, Silje W., et al.
Publicado: (2022)

Wrong schools or wrong students? The potential role of medical education in regional imbalances of the health workforce in the United Republic of Tanzania
por: Leon, Beatus K, et al.
Publicado: (2010)

PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patients
por: Sponaas, Anne-Marit, et al.
Publicado: (2018)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
por: Søraas, Arne, et al.
Publicado: (2022)

Sa1052: IMMUNOGENICITY AND SAFETY OF STANDARD AND THIRD DOSE SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES; A PROSPECTIVE COHORT STUDY
por: Joergensen, Kristin K., et al.
Publicado: (2022)

Practicing Integrated Care Pathways in Norwegian Hospitals: Coordination through Industrialized Standardization, Value Chains, and Quality Management or an Organizational Equivalent to Improvised Jazz Standards
por: Mæhle, Per Magnus, et al.
Publicado: (2020)

Diffraktive Anregungen eine Protons in hadronischen Vielteilchen-Reaktionen
por: Nissen-Meyer, Sven-Audun
Publicado: (1975)

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
por: Cortese, Marianna, et al.
Publicado: (2015)

Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study
por: Bjørnevik, Kjetil, et al.
Publicado: (2016)

Monitoring multiple myeloma by quantification of recurrent mutations in serum
por: Rustad, Even Holth, et al.
Publicado: (2017)

Phylogenetic and functional conservation of the NKR-P1F and NKR-P1G receptors in rat and mouse
por: Kveberg, Lise, et al.
Publicado: (2011)

Tuberculin responses after BCG vaccination predict amyotrophic lateral sclerosis risk
por: Nakken, Ola, et al.
Publicado: (2023)

A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo
por: Giannakopoulou, Eirini, et al.
Publicado: (2023)

Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study
por: Romanowska, Julia, et al.
Publicado: (2023)

Soluble T-Cell Receptors Produced in Human Cells for Targeted Delivery
por: Walseng, Even, et al.
Publicado: (2015)

Mind the Differences: How Diagnoses and Hospital Characteristics Influence Coordination in Cancer Patient Pathways
por: Mæhle, Per Magnus, et al.
Publicado: (2021)

Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients—Should We Keep Vaccinating?
por: Åsberg, Anders, et al.
Publicado: (2023)

Cancer risk with folic acid supplements: a systematic review and meta-analysis
por: Wien, Tale Norbye, et al.
Publicado: (2012)

Whole-genome sequencing of mutants with increased resistance against the two-peptide bacteriocin plantaricin JK reveals a putative receptor and potential docking site
por: Ekblad, Bie, et al.
Publicado: (2017)

Sero-prevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Norway, winter/spring 2021
por: Hvalryg, Marte, et al.
Publicado: (2021)

Are doping tests in sports trustworthy?: Athletes suffer from insufficiently defined criteria for doping tests
por: Nissen‐Meyer, Jon, et al.
Publicado: (2022)

Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome
por: Rašić, Senija, et al.
Publicado: (2015)

Conductas de acoso y amenaza entre escolares /
por: Olweus, Dan, 1931-
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_d9i7lopphre6bmrbq5nps0u92i